NVAX Stock Price: Novavax Inc drops as big name biotech companies inch closer to EUA for COVID-19 vaccine

NASDAQ:NVAX falls by 4.08% amidst a broader market selloff stimulus talks stumble in America.
Novavax teams with UC Davis Health to test its coronavirus vaccine candidate.
COVID-19 vaccine makers watch on as Pfizer expects EUA on Thursday from the FDA.

Stocks Reporter FXStreet

NASDAQ:NVAX has been somewhat forgotten in the race for Emergency Use Authorization (EUA) of its COVID-19 vaccine, taking a backseat to some of the biotech giants who are anticipating approval over the next couple of weeks. Novavax dropped 4.08% on Wednesday alongside a broader market selloff as US stimulus talks hit another wall in Congress. Investors do not have much to complain about considering shares are still up nearly 3000% over the past 52-weeks, with more to come in 2021 once its COVID-19 vaccine is approved for distribution.

Novavax announced it is teaming with UC Davis Health to begin a Stage 3 clinical trial that will hopefully mean that its COVID-19 vaccine candidate NVX-CoV2373 will be approved and ready to be distributed by early to midway through 2021. For its part, Novavax has already secured some massive deals including 1 billion doses for India, whenever the vaccine can be produced. The Maryland-based biotech firm also has deals in place with Australia and Canada, amongst other countries, so 2021 could be lining up as a big year for Novavax, which still only commands a $7 billion market cap.

NVAX stock news

While Novavax is lagging behind leaders like Pfizer (NYSE:PFE) and Moderna (NASDAQ:MRNA), early results from its clinical trials had some analysts labelling Novavax as the company to beat in Operation Warp Speed. Pfizer and Moderna will have the first-mover advantage and are already the brands synonymous with ridding the world of COVID-19, but by the end of it, Novavax should be there as well and that is already evident in the large orders it has received.

Author

Stocks Reporter

FXStreet

GBP/USD hits fresh three-month highs above 1.3550

GBP/USD stretches north and refreshes three-month highs above 1.3500 in the European session on Monday. The prevalent US Dollar selling bias favors bullish traders and suggests that the path of least resistance for the pair remains to the upside.

EUR/USD extends gains above 1.1600 on USD weakness

EUR/USD extends its advance above 1.1600 in European trading hours on Monday. The US Dollar resumes its downside amid weaker-than-expected US economic data, shifting Fed expectations and fading geopolitical risk premium.

Gold looks to build strength above $4,400 amid fading Fed hike bets

Gold builds on Friday's bounce from the $4,300 neighborhood and attracts some follow-through buyers at the start of a new week. The commodity is now looking to extend momentum above the $4,400 mark, though it remains below the highest level since June 5, touched last Thursday, amid mixed fundamental cues.

Pepe defends a key support amid mixed retail demand

Pepe is up nearly 2% after a 10% decline last week, showing signs of a mild recovery, while broader crypto market risk appetite remains weak. PEPE derivatives data point to a mixed outlook, as Open Interest declines while funding rates turn positive. Technically, PEPE must hold above its $0.00000255 support floor to avoid a downside of over 10%.

Why the Fed replaced the Treasury buyers who left

When Japan moved to defend the Yen, the arrangement that drew the attention was the Federal Reserve's repo facility for foreign monetary authorities, which lets an approved foreign central bank raise dollars by temporarily handing Treasuries to the Fed rather than selling them into the market. The logic was elegant. Japan gets dollars, the Treasury market avoids a forced seller, and American long rates are spared. Coverage treated it as the mechanism that made the intervention work.

Why is Crude Oil priced for a reopening the ships haven't made?

Fourteen vessels crossed the Strait of Hormuz on Tuesday. Before the war, the count ran near 120 a day. In the sessions since the waterway was publicly declared open, Brent has drifted back to $87 and West Texas Intermediate (WTI) to $81, both a little lower again on Wednesday, with daily momentum on each unwound from the top of its range in late July to the low twenties now.